Deadline for exercise of public warrants is May
20, 2024
Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global
provider of radiation detection, measurement, analysis and
monitoring solutions to the medical, nuclear, defense, and research
end markets, previously announced on April 18, 2024, that it will
redeem all of its publicly traded warrants (the “Public Warrants”)
to purchase shares of Class A common stock, par value $0.0001 per
share (the “Common Stock”), that remain outstanding at 5:00 p.m.
New York City time on Monday, May 20, 2024 (the “Redemption Date”),
for a redemption price of $0.10 per Public Warrant (the “Redemption
Price”).
The Company wishes to remind any remaining holders of the Public
Warrants that their Public Warrants may be exercised until 5:00
p.m. New York City time on Monday, May 20, 2024. Any such Public
Warrants that remain unexercised will be void and no longer
exercisable and the holders will be entitled to receive only the
Redemption Price.
Mirion’s warrant agent, Continental Stock Transfer & Trust
Company (the “Warrant Agent”) and/or its authorized information
agent, has delivered a notice of redemption (the “Notice of
Redemption”) to the registered holders of outstanding Public
Warrants pursuant to the Warrant Agreement, dated as of June 29,
2020 (the “Warrant Agreement”), by and between Mirion (f/k/a GS
Acquisition Holdings Corp II) and the Warrant Agent.
Exercise Procedures and Deadline for Warrant Exercise
Warrant holders may continue to exercise their Public Warrants
until immediately before 5:00 p.m. New York City time on the
Redemption Date. Holders may exercise their Public Warrants and
receive Common Stock (i) in exchange for a payment in cash of the
$11.50 per Public Warrant exercise price, or (ii) on a “cashless”
basis in which case the exercising holder will receive a number of
shares of Common Stock determined under the Warrant Agreement based
on the redemption date and the redemption fair market value, as
determined in accordance with the Warrant Agreement. The “fair
market value” is based on the average last price per share of
Common Stock for the 10 trading days ending on the third trading
day prior to the date on which the Notice of Redemption was sent.
In accordance with the Warrant Agreement, exercising holders will
receive 0.220 of a share of Common Stock for each Public Warrant
surrendered for exercise. If a holder of Public Warrants would,
after taking into account all of such holders’ Public Warrants
exercised at one time, be entitled to receive a fractional interest
in a share of Common Stock, the number of shares of Common Stock
the holder is entitled to receive will be rounded down to the
nearest whole number of shares.
Holders wishing to exercise their Public Warrants should follow
the procedures described in the Notice of Redemption and the
Election to Purchase form attached thereto. Holders of Public
Warrants held in “street name” should immediately contact their
brokers to determine exercise procedures. Since the act of
exercising is voluntary, holders must instruct their brokers to
submit the Public Warrants for exercise.
Termination of Warrant Rights
The Public Warrants are listed on the NYSE under the ticker
symbol “MIR WS.” Any outstanding Public Warrants that remain
unexercised at 5:00 p.m. New York City time on the Redemption Date
will be void and no longer exercisable, except to receive the
Redemption Price or as otherwise described in the Notice of
Redemption.
How to Redeem
The shares of Common Stock underlying the Public Warrants have
been registered by the Company under the Securities Act of 1933, as
amended, and are covered by a registration statement filed on Form
S-3, as amended, with, and declared effective by, the Securities
and Exchange Commission (Registration No. 333-268445). Exercise of
Public Warrants should be directed through the broker of the
warrant holder. In addition to the broker, questions may also be
directed to Morrow Sodali at (800) 662-5200 (for individuals) /
(203) 658-9400 (for banks and brokerages) or at
mir@info.morrowsodali.com. Or contact Continental Stock Transfer
& Trust Company, One State Street, 30th Floor, New York, New
York 10004, Attention: Compliance Department, Telephone Number
(212) 509-4000.
Additional information can be found on Mirion’s Investor
Relations website: https://ir.mirion.com/
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety,
science and medicine, empowering innovations that deliver vital
protection while harnessing the transformative potential of
ionizing radiation across a diversity of end markets. The Mirion
Technologies group provides proven radiation safety technologies
that operate with precision – for essential work within R&D
labs, critical nuclear facilities, and on the front lines. The
Mirion Medical group solutions help enhance the delivery and ensure
safety in healthcare, powering the fields of Nuclear Medicine,
Radiation Therapy QA, Occupational Dosimetry, and Diagnostic
Imaging. Headquartered in Atlanta (GA – USA), Mirion employs
approximately 2,700 people and operates in 12 countries. Learn more
at mirion.com.
No Offer or Solicitation
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy any Mirion securities and shall not
constitute an offer, solicitation or sale in any jurisdiction in
which such offer, solicitation or sale would be unlawful.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended. Words such as “anticipate,” “believe,” “continue,”
“could,” “estimate”, “expect”, “hope”, “intend”, “may”, “might”,
“should”, “would”, “will”, “understand” and similar words are
intended to identify forward looking statements. These
forward-looking statements include, but are not limited to,
statements regarding redemption of the warrants. Further
information on risks, uncertainties and other factors that could
affect our financial results are included in the filings we make
with the Securities and Exchange Commission (the “SEC”) from time
to time, including our Annual Report on Form 10-K, our Quarterly
Reports on Form 10-Q and other periodic reports filed or to be
filed with the SEC.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward-looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and we do not assume any obligation to update the
forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were
made.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240513146966/en/
For investor inquiries: Jerry Estes ir@mirion.com
For media inquiries: Erin Schesny media@mirion.com
Mirion Technologies (NYSE:MIR)
過去 株価チャート
から 12 2024 まで 1 2025
Mirion Technologies (NYSE:MIR)
過去 株価チャート
から 1 2024 まで 1 2025
